Trinity Biotech PLC (TRIB)
1.58
+0.01
(+0.64%)
USD |
NASDAQ |
May 17, 16:00
1.57
-0.01
(-0.63%)
After-Hours: 20:00
Trinity Biotech Total Return Level: 1.671 for May 17, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 17, 2024 | 1.671 |
May 16, 2024 | 1.661 |
May 15, 2024 | 1.618 |
May 14, 2024 | 1.608 |
May 13, 2024 | 1.671 |
May 10, 2024 | 1.798 |
May 09, 2024 | 1.745 |
May 08, 2024 | 1.756 |
May 07, 2024 | 1.788 |
May 06, 2024 | 1.830 |
May 03, 2024 | 1.906 |
May 02, 2024 | 1.777 |
May 01, 2024 | 1.851 |
April 30, 2024 | 1.925 |
April 29, 2024 | 1.883 |
April 26, 2024 | 1.936 |
April 25, 2024 | 1.936 |
April 24, 2024 | 1.936 |
April 23, 2024 | 1.936 |
April 22, 2024 | 1.914 |
April 19, 2024 | 1.910 |
April 18, 2024 | 1.988 |
April 17, 2024 | 1.946 |
April 16, 2024 | 1.962 |
April 15, 2024 | 2.020 |
Date | Value |
---|---|
April 12, 2024 | 1.967 |
April 11, 2024 | 1.936 |
April 10, 2024 | 2.040 |
April 09, 2024 | 2.004 |
April 08, 2024 | 2.041 |
April 05, 2024 | 2.094 |
April 04, 2024 | 2.116 |
April 03, 2024 | 2.146 |
April 02, 2024 | 2.073 |
April 01, 2024 | 2.062 |
March 28, 2024 | 2.158 |
March 27, 2024 | 2.094 |
March 26, 2024 | 2.136 |
March 25, 2024 | 2.232 |
March 22, 2024 | 2.242 |
March 21, 2024 | 2.274 |
March 20, 2024 | 2.327 |
March 19, 2024 | 2.316 |
March 18, 2024 | 2.300 |
March 15, 2024 | 2.369 |
March 14, 2024 | 2.327 |
March 13, 2024 | 2.348 |
March 12, 2024 | 2.412 |
March 11, 2024 | 2.359 |
March 08, 2024 | 2.359 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
1.608
Minimum
May 14 2024
35.11
Maximum
Feb 16 2021
8.720
Average
6.610
Median
Sep 10 2019
Total Return Level Benchmarks
Avadel Pharmaceuticals PLC | 15.49 |
Amarin Corp PLC | 0.87 |
DBV Technologies SA | 0.5835 |
Adaptimmune Therapeutics PLC | 1.11 |
Akari Therapeutics PLC | 1.52 |